The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Journal club

Journal club: STEP 1 and the treatment-policy estimand — does this still hold?

G
GEldridgeTL3Regular7 Apr 2026#1

Asking directly, because I could not find a straight answer: Journal club: STEP 1 and the treatment-policy estimand — does this still hold?

Working notes on STEP 1 rather than a conclusion. I would rather post the reasoning while it can still be corrected than post the answer once I am committed to it.

Everything below is checkable. Where I have taken a figure from somewhere else I have said where; where I have estimated, I have said that too.

3 likes 4mo
KR
k.radichTL211 Apr 2026#2

The failure mode on STEP 1 is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.

7 likes 4mo
CD
c.delgadoTL214 Apr 2026#3

Thank you for taking the time. That was more work than a reply usually is.

18 likes 3mo
AL
a.lindholmTL216 Apr 2026#4

I read the opening post twice before replying, because I had assumed the opposite.

Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.

I would not lead a decision with this, but I would not ignore it either.

0 likes 3mo
B
BGiordanoTL2Member18 Apr 2026 · edited#5

One more thing on STEP 1 that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.

0 likes 3mo
BV
b.vestergaardTL220 Apr 2026#6
k.radich, post #2: The failure mode on STEP 1 is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong. Go to post

Summarising the STEP 1 thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length.

4 likes in reply to #2 3mo
CD
cannula_driftTL3Regular22 Apr 2026#7
a.lindholm, post #4: I read the opening post twice before replying, because I had assumed the opposite. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I would not lead a decision with this, but I would not ignore it either. Go to post

Narrowing post #6, because the general version has more than one answer.

The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.

That is the practical version. The rigorous version is longer and says the same thing.

13 likes in reply to #4 3mo
AM
a.mwangiTL224 Apr 2026#8

Everything in post #4 holds. The case it does not cover is the one I have.

Since STEP 1 keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will review it.

26 likes 3mo
EI
e.iyerTL226 Apr 2026#9
c.delgado, post #3: Thank you for taking the time. That was more work than a reply usually is. Go to post

The most useful reply I ever got about STEP 1 was a request to state my units. It sounds like pedantry and it has saved me twice.

0 likes in reply to #3 3mo
DV
dr.villanuevaTL3Physician28 Apr 2026#10

Post #8 describes the usual case. This is about the unusual one.

Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything that follows.

2 likes 3mo
MN
m.ndiayeTL230 Apr 2026#11
a.mwangi, post #8: Everything in post #4 holds. The case it does not cover is the one I have. Since STEP 1 keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will review it. Go to post

Everything in post #7 holds. The case it does not cover is the one I have.

The arithmetic on STEP 1 is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.

18 likes in reply to #8 3mo
BP
bench_peakTL3Regular2 May 2026#12

My position on STEP 1 is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.

7 likes 3mo
SO
s.okonkwoTL23 May 2026#13

Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.

0 likes 3mo
ID
isotonic_driftTL1Member5 May 2026#14
s.okonkwo, post #13: Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. Go to post

The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.

Posting it because the silence on this was starting to look like agreement.

0 likes in reply to #13 3mo
SV
s.vogelTL27 May 2026#15

Answering the question post #11 raises rather than the one it answers.

Second-hand on STEP 1, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.

25 likes 3mo
K
KStephanopoulosTL3Regular8 May 2026#16

Fine by me. I had wanted a stronger conclusion and there is not one available.

11 likes 3mo
TB
t.batistaTL210 May 2026 · edited#17

STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially larger than anything previously achieved pharmacologically.

1 like 3mo
I
IsaksenTL3Regular12 May 2026#18
KStephanopoulos, post #16: Fine by me. I had wanted a stronger conclusion and there is not one available. Go to post

Where the STEP 1 discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.

0 likes in reply to #16 3mo
NN
n.nakamuraTL213 May 2026#19
Isaksen, post #18: Where the STEP 1 discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on. Go to post

The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.

Somebody will have a better source than mine, and I hope they post it.

8 likes in reply to #18 3mo
CN
c.niemelTL3Regular15 May 2026#20

Something worth flagging about STEP 1: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a coincidence.

2 likes 2mo
I
IsaksenTL3Regular16 May 2026#21
s.okonkwo, post #13: Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. Go to post

Confirming post #20 from a second method, which matters more than confirming it from a second person.

The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.

If anyone has run this properly I would rather read that than my own guess.

1 like in reply to #13 2mo
AE
a.eriksenTL218 May 2026 · edited#22

My experience of STEP 1 contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.

0 likes 2mo
VD
vial_deskTL3Regular19 May 2026#23

Appreciated. The plain phrasing does more work here than a longer post would.

3 likes 2mo
MA
m.adebayoTL221 May 2026#24

Post #22 describes the usual case. This is about the unusual one.

Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then limitations. That order makes critique coherent.

The general case is well covered; this is the awkward specific one.

11 likes 2mo
AP
abstract_peakTL1Member22 May 2026#25
Isaksen, post #18: Where the STEP 1 discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on. Go to post

The question underneath STEP 1 is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it.

Write down what you would expect to see under each hypothesis before you collect anything. If they predict the same observation, collecting it will not help.

23 likes in reply to #18 2mo
NA
n.achebeTL224 May 2026#26

I would put moderate confidence on the mainstream reading of STEP 1 and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.

0 likes 2mo
TN
t.nardoneTL3Regular25 May 2026#27

The arithmetic in post #24 is right; the assumption feeding it is the part to check.

Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.

None of the above is medical advice and I am not qualified to give any.

1 like 2mo
TI
t.ibarraTL227 May 2026#28
bench_peak, post #12: My position on STEP 1 is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly. Go to post

Answering the question post #26 raises rather than the one it answers.

The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.

I would call that likely rather than established.

7 likes in reply to #12 2mo
DO
d.oyelaranTL3Pharmacist28 May 2026#29

Posting my STEP 1 numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular answer.

6 likes 2mo
NK
n.krastevTL230 May 2026#30

STEP 1: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know which.

15 likes 2mo